4 Einträge gefunden

1. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

   1. Minner, Sarah Jane Pauline
   2. Jessen, Birte
   3. Stiedenroth, Lars
   4. Burandt, Eike Christian
   5. Köllermann, Jens
   6. Mirlacher, Martina
   7. Erbersdobler, Andreas

   2010 - Forschungsinformationssystem des UKE
2. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

   1. Fleischmann, Achim
   2. Schlomm, Thorsten
   3. Köllermann, Jens
   4. Sekulic, Nikolina
   5. Huland, Hartwig
   6. Mirlacher, Martina
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
3. Clinical significance of p53 alterations in surgically treated prostate cancers.

   1. Schlomm, Thorsten
   2. Iwers, Liv
   3. Kirstein, Patrick
   4. Jessen, Birte
   5. Köllermann, Jens
   6. Minner, Sarah
   7. Passow-Drolet, Annika

   2008 - Forschungsinformationssystem des UKE
4. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

   1. Fleischmann, Achim
   2. Schlomm, Thorsten
   3. Huland, Hartwig
   4. Köllermann, Jens
   5. Simon, Philipp
   6. Mirlacher, Martina
   7. Salomon, Georg

   2008 - Forschungsinformationssystem des UKE